DMs also tend to have lower DNA copy number alterations than other melanoma subtypes; the few focal deletions that have been observed target CDKN2A and NF1, whereas amplifications affect EGFR, CDK4, MDM2, TERT, MAP3K1, MET, YAP1 and NFKBIE13. This evidence concerns the gene NF1 and melanoma.